The status of diabetes control and antidiabetic drug therapy in Japan--a cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1)

Diabetes Research and Clinical Practice
Masashi KobayashiJapan Diabetes Clinical Data Management Study Group

Abstract

The number of diabetic patients has been increasing in Japan and consequently diabetic complications are the most important target to be prevented through improving glycemic control. In order to describe the glycemic control status and treatment of diabetic patients by specialists in Japan over three years, from 2000 to 2002, we examined HbA1c, other laboratory data and the modality of drug therapy in the study population, 8170 in 2000, 11,831 in 2001, and 16,934 in 2002. Patients were registered at clinics and hospitals that were members of the Japan Diabetes Clinical Data Management Study Group (JDDM). HbA1c levels, other laboratory data, and details of drug therapy were collected and analyzed using SPSS and MS Access. The mean HbA1c levels were essentially unchanged during the study periods, ranging from 7.9% to 7.8%, and from 7.1% to 7.0%, in type 1 and type 2 diabetic patients, respectively. In type 2 diabetes, the frequency of oral hypoglycemic agents (OHA) use increased from 44.9% to 51.4%, while the use of diet-only therapy decreased from 29.9% to 25.4% over the study period. Although the systolic blood pressure was slightly above target, the mean blood pressure and the mean lipid profile were mostly within the treatmen...Continue Reading

References

Sep 21, 2002·Current Medical Research and Opinion·W NitiyanantJ P Yeo

❮ Previous
Next ❯

Citations

Nov 6, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hiroki YokoyamaUNKNOWN Japan Diabetes Clinical Data Management Study Group
Dec 15, 2010·BMC Endocrine Disorders·Deepson S ShyangdanNorman R Waugh
May 8, 2009·Nutrition & Metabolism·Hajime HaimotoHiroyuki Umegaki
Mar 19, 2013·Endocrine Journal·Mitsuyoshi TakaharaIichiro Shimomura
May 31, 2013·Endocrine Journal·Junji FujikuraKazuwa Nakao
Aug 30, 2008·Endocrine Journal·Keiko AraiUNKNOWN Japan Diabetes Clinical Data Management Study Group
Nov 15, 2011·Journal of Atherosclerosis and Thrombosis·Mitsuyoshi TakaharaIichiro Shimomura
Jul 18, 2014·Internal Medicine·Eiko TakahashiUNKNOWN Ningen Dock Database Group
Jan 12, 2010·Diabetes Research and Clinical Practice·Edson Duarte MoreiraUNKNOWN Venezuelan Diabetes Investigators' Group
Oct 16, 2007·Diabetes Research and Clinical Practice·Kenji NonakaPeter P Stein
Nov 27, 2007·Clinical Therapeutics·Robert J LigthelmPaul Valensi
Dec 17, 2011·Journal of Transplantation·Yuko YamamotoKeiko Kazuma
Oct 2, 2009·Diabetes/metabolism Research and Reviews·Susan E NevilleRisa P Hayes
May 20, 2008·Health & Social Care in the Community·Hirohide YokokawaSeiji Yasumura
Dec 3, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·H YokoyamaUNKNOWN Japan Diabetes Clinical Data Management Study Group
Feb 12, 2009·Journal of Clinical Periodontology·Sayaka MatsumotoHideo Miyazaki
Apr 5, 2013·Annals of the New York Academy of Sciences·Ronald C W Ma, Juliana C N Chan
Jan 29, 2013·Journal of Diabetes Investigation·Yasuhiko IwamotoKohei Kaku
Mar 18, 2013·Journal of Diabetes Investigation·Yukiko OnishiMarilyn K Boardman
Mar 7, 2014·Diabetes Research and Clinical Practice·Eiko TakahashiUNKNOWN Ningen Dock Database Group
Aug 28, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Nozomi DomekiYoshimasa Aso
Oct 14, 2016·Journal of Stroke·Young Dae KimGustavo Saposnik
May 12, 2009·Diabetes Research and Clinical Practice·N YoshiokaT Koike

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.